Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 251.18M
March 31, 2026 256.20M
December 31, 2025 520.75M
September 30, 2025 541.08M
June 30, 2025 521.00M
March 31, 2025 516.83M
December 31, 2024 439.12M
September 30, 2024 355.96M
June 30, 2024 374.08M
March 31, 2024 443.76M
December 31, 2023 401.35M
September 30, 2023 295.16M
June 30, 2023 196.08M
March 31, 2023 -21.94M
December 31, 2022 21.04M
September 30, 2022 51.02M
June 30, 2022 133.17M
March 31, 2022 168.54M
December 31, 2021 101.72M
September 30, 2021 138.04M
June 30, 2021 115.46M
March 31, 2021 77.97M
December 31, 2020 82.84M
September 30, 2020 57.57M
June 30, 2020 28.34M
Date Value
March 31, 2020 9.593M
December 31, 2019 72.08M
September 30, 2019 90.52M
June 30, 2019 93.03M
March 31, 2019 148.33M
December 31, 2018 99.28M
September 30, 2018 74.68M
June 30, 2018 60.68M
March 31, 2018 6.099M
December 31, 2017 19.19M
September 30, 2017 -12.59M
June 30, 2017 -17.34M
March 31, 2017 -23.76M
December 31, 2016 -67.23M
September 30, 2016 -68.94M
June 30, 2016 -113.12M
March 31, 2016 -99.65M
December 31, 2015 -40.36M
September 30, 2015 -29.13M
June 30, 2015 -7.495M
March 31, 2015 16.69M
December 31, 2014 11.14M
September 30, 2014 35.60M
June 30, 2014 29.48M
March 31, 2014 33.44M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Amarin Corp. Plc 15.55M
Jazz Pharmaceuticals Plc 1.661B
Prothena Corp. Plc -61.42M
ACADIA Pharmaceuticals, Inc. 160.32M
Biogen, Inc. 2.879B